Target intelligence / Profile preview

Mitochondrial ATP synthase beta subunit (ATP5B)

Target
ATP5B
Molecular classification
Enzyme, Rotary motor protein, Mitochondrial protein
01

Overview

The mitochondrial ATP synthase beta subunit is a principal component of the F1 catalytic core of the ATP synthase enzyme complex, which is embedded in the mitochondrial inner membrane. The ATP synthase operates as a rotary molecular motor: the beta subunit hosts the catalytic nucleotide binding sites where ADP and inorganic phosphate are converted to ATP using energy derived from a proton gradient across the membrane. Three beta and three alpha subunits form a hexameric ring structure in the F1 domain; the beta subunits alternate with alpha subunits, and together they enable the binding-exchange mechanism of ATP synthesis. Dysfunction or mutation in this subunit can impair cellular energy metabolism, contribute to mitochondrial diseases, and has been linked to pathologies such as cancer via mitochondrial bioenergetic reprogramming.

Other names
ATP synthase F1 complex beta subunitATP5BF1-ATPase betaF-ATPase betaATP synthase subunit beta
02

Mechanism of action

Inhibitors block proton flow or rotation, halting ATP production and mitochondrial energy generation Modulators may stabilize or destabilize the enzyme, affecting cellular energy status

03

Biological functions

ATP synthesisMaintenance of cellular energy balanceRegulation of mitochondrial transmembrane potentialPossible involvement in cell death processes (apoptosis)
04

Disease associations

Mitochondrial diseasesCancerNeurodegenerative disease (proposed involvement in mitochondrial permeability transition pore formation)Cardiovascular disease (energy metabolism disorders)
05

Safety considerations

Inhibition impairs cellular ATP production and may cause cytotoxicity due to energy failure in non-target tissuesEssential for viability of all cell types, so complete inhibition is not therapeutically viable except in highly targeted contexts
06

Interacting drugs

Oligomycin (inhibitor)

1 more in the full profile.

07

Biomarkers

ATP synthase beta subunit expression may be altered in cancers and mitochondrial disorders; levels can indicate mitochondrial function

Beyond the preview

Go deeper on Mitochondrial ATP synthase beta subunit (ATP5B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial ATP synthase beta subunit (ATP5B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call